Topical treatment of periocular basal cell epithelioma with solcoderm.
25 patients with 29 histologically confirmed periocular basal cell epitheliomas were treated by topical application of Solcoderm, a solution of organic and inorganic acids and ions. The cure rate of the 29 lesions, which were followed for a mean period of 32 months, was 80%. The overall cure rate following second Solcoderm treatment of the 6 recurrent lesions was 96.7%. The cosmetic and functional results were excellent and there were no serious complications and side effects.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D019342:Acetic Acid; D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D003231:Conjunctivitis / Q000139:chemically induced; D003300:Copper / Q000009:adverse effects / Q000627:therapeutic use; D005142:Eyelid Neoplasms / Q000188:drug therapy*; D006801:Humans; D007773:Lactates / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use; D011817:Rabbits
D000085:Acetates; D007773:Lactates; D009566:Nitrates; D003300:Copper; D019342:Acetic Acid